Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review. | Front Immunol | 2023 | 37753079 | PubTator, text mining | PubMed |
| Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis. | Front Immunol | 2023 | 37753072 | PubTator, text mining | PubMed |
| Genome-wide association study identifying variants related to performance and injury in high-performance athletes. | Exp Biol Med (Maywood) | 2023 | 37750015 | PubTator, text mining | PubMed |
| Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series. | J Med Case Rep | 2023 | 37749657 | PubTator, text mining | PubMed |
| S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection. | Microbiol Spectr | 2023 | 37737609 | PubTator, text mining | PubMed |
| Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migration. | J Cell Biol | 2023 | 37733372 | PubTator, text mining | PubMed |
| Discovering immunoreceptor coupling and organization motifs. | Front Immunol | 2023 | 37731510 | PubTator, text mining | PubMed |
| Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88. | Drug Des Devel Ther | 2023 | 37719363 | PubTator, text mining | PubMed |
| Alterations of fecal microbiome and metabolome in pemphigus patients. | J Autoimmun | 2023 | 37714737 | PubTator, text mining | PubMed |
| Skin-Related Quality of Life During Autoimmune Bullous Disease Course. | JAMA Dermatol | 2023 | 37703003 | PubTator, text mining | PubMed |
| Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patients. | Front Allergy | 2023 | 37692891 | PubTator, text mining | PubMed |
| Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS. | Molecules | 2023 | 37687176 | PubTator, text mining | PubMed |
| Identification of a novel COL7A1 variant associated with dystrophic epidermolysis bullosa pruriginosa responding effectively to dupilumab. | Mol Genet Genomic Med | 2023 | 37676173 | PubTator, text mining | PubMed |
| Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients. | Front Cell Dev Biol | 2023 | 37675143 | PubTator, text mining | PubMed |
| Structural basis for abscisic acid efflux mediated by ABCG25 in Arabidopsis thaliana. | Nat Plants | 2023 | 37666962 | PubTator, text mining | PubMed |
| Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer. | Front Oncol | 2023 | 37664033 | PubTator, text mining | PubMed |
| The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update. | Front Mol Biosci | 2023 | 37654796 | PubTator, text mining | PubMed |
| The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma. | Cancer Med | 2023 | 37654227 | PubTator, text mining | PubMed |
| A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine. | J Dermatol | 2023 | 37641883 | PubTator, text mining | PubMed |
| Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma. | Infect Agent Cancer | 2023 | 37641095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=16